TRISON RESEARCH LABORATORIES products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Sargodha · Pakistan
Sargodha-based pharmaceutical manufacturer established in 2009 and operating from the Punjab Small Industrial Estate.
TRISON RESEARCH LABORATORIES products in Pakistan
TRISON RESEARCH LABORATORIES PRIVATE LIMITED has 40 medicine presentations registered in Pakistan under 20 brands, covering 20 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are Ciprose (Ciprofloxacin), Maksin (Azithromycin), Jostle (Ceftriaxone) and Pert (Cefotaxime). 40 products have an official DRAP price on MedInfoBase. See all 20 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Private pharmaceutical manufacturer
- Address
- 27-A, Punjab Small Industrial Estate, Sargodha, Punjab, Pakistan
- Website
- trisonlabs.com ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 63%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where TRISON RESEARCH LABORATORIES PRIVATE LIMITED is priced against the market
39 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| ARK 1gm IV InjectionRegistry verified | Cefepime (As HCl) | — | — | — | 045477Official source ↗ | No indexed price | — | — |
| ARK 500mg IV InjectionRegistry verified | Cefepime (As HCl) | — | — | — | 045478Official source ↗ | No indexed price | — | — |
| Ciprose | Ciprofloxacin | 125 mg/5 mL | Dry suspension | 60ml | 063302 | PKR 222.36 | PKR 3.71/mL | 🔒 Pharma Pro |
| Ciprose | Ciprofloxacin | 250 mg/5 mL | Dry suspension | 60ml | 063303 | PKR 295.45 | PKR 4.92/mL | 🔒 Pharma Pro |
| Ciprose | Ciprofloxacin | 500 mg | Tablet | 1x10 | 063339 | PKR 397.02 | PKR 39.70/tablet | 🔒 Pharma Pro |
| Ciprose | Ciprofloxacin | 250 mg | Tablet | 1x10 | 063340 | PKR 240.06 | PKR 24.01/tablet | 🔒 Pharma Pro |
| Dicol D | Cholecalciferol | 5 mg/mL | Injection | 5's | 124566 | PKR 862.36 | PKR 172.47/vial/unit | 🔒 Pharma Pro |
| Dicol D | Cholecalciferol | 5 mg/mL | Injection | 1's | 124566 | PKR 203.12 | PKR 203.12/vial/unit | 🔒 Pharma Pro |
| Esomer 40mg InjectionRegistry verified | Esomeprazole Sodium eq. to Esomeprazole | — | — | — | 124631Official source ↗ | No indexed price | — | — |
| Fender 1g IV InjectionRegistry verified | Cefoperazone (As Sodium), Sulbactum (As Sodium) | — | — | — | 045488Official source ↗ | No indexed price | — | — |
| Fender 2g IV InjectionRegistry verified | Cefoperazone (As Sodium), Sulbactum (As Sodium) | — | — | — | 045487Official source ↗ | No indexed price | — | — |
| Jostle | Ceftriaxone | 250 mg | Injection | 1's | 045479 | PKR 186.51 | PKR 186.51/vial/unit | 🔒 Pharma Pro |
| Jostle | Ceftriaxone | 500 mg | Injection | 1's | 045480 | PKR 313.92 | PKR 313.92/vial/unit | 🔒 Pharma Pro |
| Jostle | Ceftriaxone | 1 g | Injection | 1's | 045481 | PKR 592.75 | PKR 592.75/vial/unit | 🔒 Pharma Pro |
| Lozet | Letrozole | 2.5 mg | Tablet | 30's | 113757 | PKR 11,079.51 | PKR 369.32/tablet | 🔒 Pharma Pro |
| Maksin | Azithromycin | 200 mg | Suspension | 15ml | 063301 | PKR 304.69 | PKR 20.31/mL | 🔒 Pharma Pro |
| Maksin | Azithromycin | 250 mg | Tablet | 1x10 | 063330 | PKR 470.88 | PKR 47.09/tablet | 🔒 Pharma Pro |
| Maksin | Azithromycin | 250 mg | Capsule | 6’s | 090079 | PKR 282.53 | PKR 47.09/capsule | 🔒 Pharma Pro |
| Maksin | Azithromycin | 250 mg | Capsule | 10’s | 090079 | PKR 470.88 | PKR 47.09/capsule | 🔒 Pharma Pro |
| Momtek | Loratadine | 10 mg | Tablet | 1x10 | 032787 | PKR 132.95 | PKR 13.30/tablet | 🔒 Pharma Pro |
| Penxime | Cefixime | 100 mg/5 mL | Suspension | 30 ml | 045476 | PKR 314.24 | PKR 10.47/mL | 🔒 Pharma Pro |
| Pert | Cefotaxime | 250 mg | Injection | 1's | 045482 | PKR 105.46 | PKR 105.46/vial/unit | 🔒 Pharma Pro |
| Pert | Cefotaxime | 500 mg | Injection | 1's | 045483 | PKR 158.95 | PKR 158.95/vial/unit | 🔒 Pharma Pro |
| Pert | Cefotaxime | 1 g | Injection | 1's | 045484 | PKR 285.88 | PKR 285.88/vial/unit | 🔒 Pharma Pro |
| Qucin | Levofloxacin | 250 mg | Tablet | 1x10 | 063328 | PKR 461.65 | PKR 46.17/tablet | 🔒 Pharma Pro |
| Qucin | Levofloxacin | 500 mg | Tablet | 1x10 | 063329 | PKR 768.18 | PKR 76.82/tablet | 🔒 Pharma Pro |
| Shozupril | Enalapril | 10 mg | Tablet | 2 x10 | 033907 | PKR 121.87 | PKR 6.09/tablet | 🔒 Pharma Pro |
| T-Van | Vancomycin | 500 mg | Injection | 1's | 124564 | PKR 1,292.61 | PKR 1,292.61/vial/unit | 🔒 Pharma Pro |
| T-Van | Vancomycin | 1 g | Injection | 1's | 124565 | PKR 2,086.64 | PKR 2,086.64/vial/unit | 🔒 Pharma Pro |
| Taramol | Paracetamol | 500 mg | Tablet | 20x10’s | 063338 | PKR 762.93 | PKR 3.81/tablet | 🔒 Pharma Pro |
| Temox | Moxifloxacin | 400 mg | Tablet | 5’s | 090071 | PKR 877.13 | PKR 175.43/tablet | 🔒 Pharma Pro |
| Tesso | Omeprazole | 20 mg | Capsule | 100’s | 090080 | PKR 1,822.58 | PKR 18.23/capsule | 🔒 Pharma Pro |
| Tesso | Omeprazole | 20 mg | Capsule | 10’s | 090080 | PKR 190.20 | PKR 19.02/capsule | 🔒 Pharma Pro |
| Tesso | Omeprazole | 20 mg | Capsule | 14’s | 090080 | PKR 265.91 | PKR 18.99/capsule | 🔒 Pharma Pro |
| Tesso 40mg InjectionRegistry verified | Omeprazole sodium | — | — | — | 131752Official source ↗ | No indexed price | — | — |
| Throcin | Clarithromycin | 125 mg/5 mL | Dry suspension | 60ml | 063305 | PKR 411.79 | PKR 6.86/mL | 🔒 Pharma Pro |
| Throcin | Clarithromycin | 250 mg | Tablet | 1x10 | 063333 | PKR 443.18 | PKR 44.32/tablet | 🔒 Pharma Pro |
| Throcin | Clarithromycin | 500 mg | Tablet | 1x10 | 063334 | PKR 821.73 | PKR 82.17/tablet | 🔒 Pharma Pro |
| Trifocin | Fosfomycin | 250 mg | Suspension | 60ml | 063304 | PKR 166.19 | PKR 2.77/mL | No comparator |
| Trimazole | Clotrimazole | 500 mg | Tablet | 1's | 063331 | PKR 118.18 | PKR 118.18/tablet | 🔒 Pharma Pro |
| Trimether | Artemether + Lumefantrine | 15 mg + 90 mg | Suspension | 30ml | 063306 | PKR 160.65 | PKR 5.36/mL | 🔒 Pharma Pro |
| Trimether | Artemether + Lumefantrine | 15 mg + 90 mg | Suspension | 60ml | 063306 | PKR 323.15 | PKR 5.39/mL | 🔒 Pharma Pro |
| Trimether | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8's | 063332 | PKR 487.50 | PKR 60.94/tablet | 🔒 Pharma Pro |
| Trivon | Ondansetron | 8 mg/4 mL | Injection | 5's | 124561 | PKR 4,773.42 | PKR 954.68/vial/unit | 🔒 Pharma Pro |
| Trivon | Ondansetron | 8 mg/4 mL | Injection | 1's | 124561 | PKR 954.68 | PKR 954.68/vial/unit | 🔒 Pharma Pro |
| Wastatin | Simvastatin | 10 mg | Tablet | 1x10 | 032785 | PKR 306.53 | PKR 30.65/tablet | 🔒 Pharma Pro |
All 20 TRISON RESEARCH LABORATORIES brands in Pakistan
- Ciprose Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- Dicol D Cholecalciferol · 5 mg/mL injection
- Jostle Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Lozet Letrozole · 2.5 mg tablet
- Maksin Azithromycin · 200 mg suspension, 250 mg tablet, 250 mg capsule
- Momtek Loratadine · 10 mg tablet
- Penxime Cefixime · 100 mg/5 mL suspension
- Pert Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Qucin Levofloxacin · 250 mg tablet, 500 mg tablet
- Shozupril Enalapril · 10 mg tablet
- T-Van Vancomycin · 1 g injection, 500 mg injection
- Taramol Paracetamol · 500 mg tablet
- Temox Moxifloxacin · 400 mg tablet
- Tesso Omeprazole · 20 mg capsule
- Throcin Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Trifocin Fosfomycin · 250 mg suspension
- Trimazole Clotrimazole · 500 mg tablet
- Trimether Artemether + Lumefantrine · 15 mg + 90 mg suspension, 40 mg + 240 mg tablet
- Trivon Ondansetron · 8 mg/4 mL injection
- Wastatin Simvastatin · 10 mg tablet
TRISON RESEARCH LABORATORIES: common questions
How many products does TRISON RESEARCH LABORATORIES have in Pakistan?
TRISON RESEARCH LABORATORIES PRIVATE LIMITED has 40 registered medicine presentations in Pakistan, sold under 20 brands and covering 20 generic medicines.
What are the main brands of TRISON RESEARCH LABORATORIES?
By number of registered strengths and packs, its largest brands are Ciprose (Ciprofloxacin), Maksin (Azithromycin), Jostle (Ceftriaxone), Pert (Cefotaxime) and Tesso (Omeprazole). This is not a sales ranking.
Which therapy areas does TRISON RESEARCH LABORATORIES cover?
The most products are in Anti-infectives (28), Gastrointestinal & hepatology (5), Vitamins, minerals & nutrition (2), Cardiovascular (2) and Oncology & immunology (1).
Where can I see TRISON RESEARCH LABORATORIES medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.